Current Standard and Future Perspectives in First- and Second-Line Treatment of Metastatic Pancreatic Adenocarcinoma

Publisher： Karger

E-ISSN： 1421-9867|94|1|44-49

ISSN： 0012-2823

Source： Digestion, Vol.94, Iss.1, 2016-07, pp. : 44-49

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modified GTX as Second-Line Therapy for Advanced Pancreatic Adenocarcinoma

By Ajouz Hana   Mukherji Deborah   Haydar Ali   Yakan Ahmad   Saleh Ahmad   Elias Elias   Temraz Sally   Faraj Walid   Khalife Mohammad   Shamseddine Ali  

Journal of Gastrointestinal Cancer, Vol. 45, Iss. 1, 2014-03 ,pp. : 109-112

Springer Publishing Company

Access to resources Recommend Favorite

Current Standard and Future Perspectives in the Treatment of Gastrointestinal Stromal Tumors

By  

Digestion, Vol. 95, Iss. 4, 2017-04 ,pp. : 262-268

Karger

Access to resources Recommend Favorite

Mouse Models of Metastatic Pancreatic Adenocarcinoma

By Xie K.   Wang B.   Shi Q.   Abbruzzese J.L.   Xiong Q.   Le X.  

International Journal of Pancreatology, Vol. 29, Iss. 1, 2001-03 ,pp. : 25-35

Humana Press, Inc

Access to resources Recommend Favorite

Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma

By  

Digestion, Vol. 96, Iss. 1, 2017-06 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

A Novel, Clinically Relevant Animal Model of Metastatic Pancreatic Adenocarcinoma Biology and Therapy

By Wang B.   Shi Q.   Abbruzzese J.L.   Xiong Q.   Le X.   Xie K.  

International Journal of Pancreatology, Vol. 29, Iss. 1, 2001-03 ,pp. : 37-46

Humana Press, Inc

Access to resources Recommend Favorite